ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Dr Reddy's Lab Q3 results: PAT up 11%, beats estimates on strong US sales
The Hyderabad-based drug major had reported a net profit of Rs 1,247 crore for the October-December quarter of the last fiscal
Announcement as on 30 January 2024

Dr Reddy's Q3 Results: Net profit rises 11% YoY to Rs 1,379 crore, meets estimates
DRL Q3 Results: The profit was slightly above the ET Now poll estimate of Rs 1,337 crore. Revenue from operations increased 7% year-on-year (YoY) to Rs 7,215 crore. EBITDA for the reporting period stood at Rs 2,111 crore, while margins came in at 28%.
Announcement as on 30 January 2024

Dr Reddy's Lab Q3 results: Net profit rises 11% on strong US, EU sales
For the Indian business in Q3 FY24, the revenue stood at Rs 1,180 crore Y-o-Y with a growth of 5 per cent and a sequential decline of 1 per cent
Announcement as on 30 January 2024

Dr Reddy's Q3 Results: Net profit jumps 11% YoY to Rs 1,379 crore
The company said the net profit was led by new products and base business market share gain in the US, and also new launches and strong volumes in Europe
Announcement as on 30 January 2024

Dr Reddy’s Q3 Results Preview: Profit may drop on Lower Revlimid sales, higher costs
The drugmaker is expected to report a 1.1% YoY drop in consolidated net profit to Rs 1,247 crore, according to the average of estimates given by seven brokerages. The company is scheduled to release its quarterly earnings on Tuesday.
Announcement as on 29 January 2024

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 14.3
  • 12Day Average: 14.53
  • 20Day Average: 14.04
  • 50Day Average: 13.66
  • 100Day Average: 13.76
  • 150Day Average: 13.77
  • 200Day Average: 13.84

RDY Indicators & signals

Indicator MACD (12,26,9)

14.3, 14.05, 0.27
Indicator MACD is in positive zone

Indicator ADX (14)

3.45, 34.15, 36.59
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 54
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
08 Wed Jul 2026 14.12 13.85 to 14.59 -3.49% 1.15 times
07 Tue Jul 2026 14.63 14.34 to 14.72 1.88% 0.81 times
06 Mon Jul 2026 14.36 14.23 to 14.38 -0.14% 0.35 times
02 Thu Jul 2026 14.38 14.16 to 14.48 2.79% 0.64 times
01 Wed Jul 2026 13.99 13.95 to 14.43 -3.45% 1.05 times
30 Tue Jun 2026 14.49 14.45 to 14.70 -2.49% 1 times
29 Mon Jun 2026 14.86 14.66 to 15.13 -3.38% 1.57 times
26 Fri Jun 2026 15.38 15.30 to 15.67 0.85% 1.09 times
25 Thu Jun 2026 15.25 14.61 to 15.27 4.02% 1.36 times
24 Wed Jun 2026 14.66 14.20 to 14.66 2.45% 0.92 times
23 Tue Jun 2026 14.31 13.80 to 14.31 2.88% 1.22 times
22 Mon Jun 2026 13.91 13.45 to 14.03 4.67% 0.95 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

 

Back to top